X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (225) 225
animals (162) 162
pyrans - pharmacology (161) 161
humans (97) 97
male (97) 97
rats (84) 84
pharmacology & pharmacy (68) 68
pyrans - chemistry (50) 50
chemistry, medicinal (47) 47
dose-response relationship, drug (45) 45
mice (40) 40
biochemistry & molecular biology (37) 37
rats, sprague-dawley (35) 35
picolines - pharmacology (32) 32
pyrans - chemical synthesis (32) 32
female (30) 30
structure-activity relationship (30) 30
in vitro techniques (27) 27
chemistry, organic (25) 25
analysis (24) 24
pyrans - therapeutic use (24) 24
molecular structure (23) 23
neurosciences (23) 23
potassium channels - drug effects (23) 23
indoles - pharmacology (20) 20
cells, cultured (19) 19
enzyme inhibitors - pharmacology (19) 19
pyrans - metabolism (19) 19
vasodilator agents - pharmacology (19) 19
activation (18) 18
benzopyrans - pharmacology (18) 18
article (17) 17
pyrans (17) 17
cell line, tumor (16) 16
cromakalim (16) 16
ligands (16) 16
pyrroles - pharmacology (16) 16
cancer (15) 15
cell biology (15) 15
derivatives (15) 15
rats, wistar (15) 15
receptors (15) 15
guinea pigs (14) 14
inhibition (14) 14
pharmacology (14) 14
phosphorylation (14) 14
apoptosis - drug effects (13) 13
dronabinol - analogs & derivatives (13) 13
dronabinol - pharmacology (13) 13
inhibitors (13) 13
melatonin (13) 13
neurons - drug effects (13) 13
antineoplastic agents - pharmacology (12) 12
apoptosis (12) 12
cell proliferation - drug effects (12) 12
oxidative stress (12) 12
potassium channels - agonists (12) 12
pyrans - administration & dosage (12) 12
rat (12) 12
analogs (11) 11
binding (11) 11
biology (11) 11
cell line (11) 11
expression (11) 11
kinetics (11) 11
rabbits (11) 11
smooth-muscle (11) 11
spiro compounds (11) 11
time factors (11) 11
brain (10) 10
cardiac & cardiovascular systems (10) 10
cells (10) 10
disease models, animal (10) 10
endocrinology & metabolism (10) 10
glyburide - pharmacology (10) 10
muscle, smooth, vascular - drug effects (10) 10
physiological aspects (10) 10
pyrans - pharmacokinetics (10) 10
pyrazoles - pharmacology (10) 10
receptor (10) 10
receptors, melatonin - agonists (10) 10
vasodilation - drug effects (10) 10
agonist (9) 9
antagonist (9) 9
antifungal agents - pharmacology (9) 9
antineoplastic agents - chemistry (9) 9
chemistry, multidisciplinary (9) 9
gene expression (9) 9
membrane potentials - drug effects (9) 9
multidisciplinary sciences (9) 9
nitric-oxide (9) 9
pharmacology/toxicology (9) 9
phenols (9) 9
piperidines - pharmacology (9) 9
plant extracts - pharmacology (9) 9
potassium channels (9) 9
receptor, cannabinoid, cb1 - antagonists & inhibitors (9) 9
receptor, cannabinoid, cb1 - metabolism (9) 9
rodents (9) 9
signal transduction - drug effects (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2012, Volume 55, Issue 21, pp. 9240 - 9254
Journal Article
Journal Article
Journal Article
Naunyn-Schmiedeberg's Archives of Pharmacology, ISSN 0028-1298, 5/2016, Volume 389, Issue 5, pp. 511 - 519
Melatonin is known as a strong antioxidant and possesses anti-inflammatory properties. Recently, melatonin was shown to improve colitis in animal models of... 
Neurosciences | Inflammatory bowel diseases | Melatonin | Biomedicine | Colitis | Pharmacology/Toxicology | Melatonin receptor agonists | CELLS | METABOLITES | ACTIVATION | RATS | MECHANISMS | ANTIOXIDANT | PHARMACOLOGY & PHARMACY | EXPRESSION | AMK | Gastrointestinal diseases | Analysis | Index Medicus | Original
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 10/2017, Volume 812, pp. 225 - 233
Excessive glucocorticoid (GC) in type 2 diabetes mellitus (T2DM) reduces insulin sensitivity, impairs β-cell function, increases gluconeogenesis and... 
Glucose and lipid metabolism | Melatonin | HPA axis | Type 2 diabetes mellitus | Neu-P11 | STEROID TREATMENT | METABOLIC SYNDROME | 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1 | MELATONIN RECEPTOR AGONISTS | HIGH-FAT DIET | STREPTOZOTOCIN-TREATED RAT | INSULIN-RESISTANCE | GLUCOSE | PPAR-GAMMA | PHARMACOLOGY & PHARMACY | CORTISOL | Receptor, Melatonin, MT2 - agonists | Gene Expression Regulation, Enzymologic - drug effects | Rats, Wistar | Diabetes Mellitus, Type 2 - genetics | Body Weight - drug effects | Diabetes Mellitus, Type 2 - metabolism | Hippocampus - drug effects | RNA, Messenger - metabolism | 11-beta-Hydroxysteroid Dehydrogenase Type 1 - genetics | Adipose Tissue - metabolism | Fasting - blood | Adiponectin - genetics | Female | Indoles - pharmacology | Corticosterone - blood | Hypothalamus - drug effects | Pyrans - pharmacology | Pyrans - therapeutic use | PPAR gamma - genetics | Glucose Transporter Type 4 - genetics | Pituitary-Adrenal System - drug effects | RNA, Messenger - genetics | Insulin Resistance | Rats | Leptin - genetics | Hippocampus - metabolism | Receptor, Melatonin, MT1 - agonists | Animals | Diabetes Mellitus, Type 2 - physiopathology | Indoles - therapeutic use | Drinking - drug effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Adipose Tissue - drug effects | Type 2 diabetes | Brain | Corticosteroids | RNA | Drugstores | Glucose | Insulin | Dextrose | Glucose metabolism | Hyperglycemia | Pharmacy | Leptin | Physiological aspects | Insulin resistance | Index Medicus
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 09/2017, Volume 138, pp. 644 - 660
Journal Article
Neurochemistry International, ISSN 0197-0186, 2007, Volume 51, Issue 6, pp. 361 - 369
Alzheimer's disease (AD) is the most common form of dementia. Glucagon-like peptide-1 (GLP-1) gives a new genre in therapeutic targets for intervention in AD... 
Mitogen-activated protein kinase | Geniposide | Oxidative stress | Glucagon-like peptide-1 receptor | ALZHEIMER-DISEASE | geniposide | PROPERTY | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION | DEATH | INDUCTION | NEUROSCIENCES | mitogen-activated protein kinase | GLUCAGON-LIKE PEPTIDE-1 | EXENDIN-4 | GLUCOSE | glucagon-like peptide-1 receptor | DIFFERENTIATION | STRESS | oxidative stress | Neuroprotective Agents - therapeutic use | Heme Oxygenase-1 - metabolism | MAP Kinase Signaling System - physiology | Oxidative Stress - physiology | Ribosomal Protein S6 Kinases, 90-kDa - drug effects | Heme Oxygenase-1 - drug effects | Apoptosis Regulatory Proteins - drug effects | PC12 Cells | Brain - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Ribosomal Protein S6 Kinases, 90-kDa - metabolism | Glucagon-Like Peptide 1 - agonists | Proto-Oncogene Proteins c-raf - drug effects | Phosphorylation - drug effects | Neurons - drug effects | Pyrans - pharmacology | Pyrans - therapeutic use | Hydrogen Peroxide - toxicity | Receptors, Glucagon - agonists | Alzheimer Disease - physiopathology | Glucagon-Like Peptide 1 - metabolism | Enzyme Inhibitors - pharmacology | Alzheimer Disease - drug therapy | Rats | Receptors, Glucagon - metabolism | MAP Kinase Kinase Kinases - metabolism | Alzheimer Disease - enzymology | Proto-Oncogene Proteins c-raf - metabolism | Apoptosis Regulatory Proteins - metabolism | Brain - drug effects | Animals | MAP Kinase Signaling System - drug effects | Glucagon-Like Peptide-1 Receptor | Iridoids - pharmacology | Neurons - enzymology | Proto-Oncogene Proteins c-bcl-2 - drug effects | Iridoids - therapeutic use | Oxidative Stress - drug effects | Hydrogen Peroxide - antagonists & inhibitors | MAP Kinase Kinase Kinases - drug effects | Peroxides | Endothelium-derived relaxing factors | Protein kinases | Methyl ethyl ketone | Index Medicus
Journal Article
Journal Article